EligibleTrials

Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT

Recruiting · NCT03861676 · Interventional (participants receive a specific treatment) · Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

View the official record on ClinicalTrials.gov →
Prostate Cancer

Interventions studied

(18F)DCFPyLFocal brachytherapy with PSMA PET imaging

What this trial is about

The Principal Investigator's (PI) working hypothesis is that the PI can utilize the high predictive value of 18F-DCFPyl PSMA to identify clinically significant tumors in patients who will undergo brachytherapy, as well as areas which are uninvolved or contain only clinically insignificant disease. In the PI's clinical trial, the uninvolved regions (as defined by combined PET-MR-biopsy data) will not be targeted and receive only fall-off dose, which we have shown to be associated with reductions in toxicity.

Who can take part

Age range
18 Years to 100 Years
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Early Phase 1
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.